[Exagamglogene autotemcel (transfusion-dependent β-thalassaemia) - Assessment according to §35a Social Code Book V]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005120
Original Title: Exagamglogen Autotemcel (transfusionsabhängige β-Thalassämie)
Project Status: Completed
Year Published: 2023
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • beta-Thalassemia
  • Biological Products
  • Genetic Therapy
  • Gene Editing
  • Product Surveillance, Postmarketing
  • Exagamglogene
  • Beta-Thalassemia
  • Adolescent
  • Adult
  • Epidemiology
  • Insurance – Health
  • Product Surveillance – Postmarketing
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.